Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants.

Geller, F., Wu, X., Lammi, V., Abner, E., Valliere, J. T., Nastou, K., Burns, A., Rasmussen, M., Andersson, N. W., Quinn, L., Consortium, D. G., Aagaard, B., Banasik, K., Bliddal, S., Boding, L., Brunak, S., Brøns, N., Bybjerg-Grauholm, J., Christoffersen, L. A. N., … Feenstra, B. (2026). Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants.. Nature Genetics, 58(2), 299-306.

Abstract

The host genetics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have previously been studied based on cases from the earlier waves of the pandemic in 2020 and 2021, identifying 51 genomic loci associated with infection and/or severity. SARS-CoV-2 has shown rapid sequence evolution, increasing transmissibility, particularly for Omicron variants, which raises the question of whether this affected the host genetic factors. We performed a genome-wide association study of SARS-CoV-2 infection with Omicron variants, including more than 150,000 cases from four cohorts. We identified 13 genome-wide significant loci, of which only five were previously described as associated with SARS-CoV-2 infection. The strongest signal was a single nucleotide polymorphism in an intron of ST6GAL1, a gene affecting immune development and function, connected to three other associated loci (harboring MUC1, MUC5AC and MUC16) through O-glycan biosynthesis. Our study provides robust evidence for individual genetic variation related to glycosylation, translating into susceptibility to SARS-CoV-2 infections with Omicron variants.

Last updated on 04/01/2026
PubMed